SCHEMBL14980804

SCHEMBL14980804

CNc1ccc(O)c(NC(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.43
HDAC1 Q13547 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
ACHE P22303 2/20 0.41
BACE1 P56817 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR1H4 Q96RI1 1/20 0.40
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPK14 Q16539 1/20 0.39
PSMB8 P28062 1/20 0.39
NAMPT P43490 1/20 0.39
MAP4K4 O95819 1/20 0.38
EGFR P00533 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13345491 0.87 SMN1; SMN2 (0.47) HDAC1CA12CA1CA9ACHE
SCHEMBL19799376 0.86 CYP17A1 (0.44) CYP17A1CA12CA1CA9RXFP1
SCHEMBL2031546 0.83 KCNMA1 (0.54) GAAMAPTHTTKCNMA1
SCHEMBL12429171 0.82 ALDH1A1 (0.52) CYP17A1ALDH1A1GAAMAPTHTT
SCHEMBL31458629 0.80 KCNMA1 (0.54) GAAHSP90AA1HSP90AB1MAPTHTT
SCHEMBL3327166 0.80 KCNMA1 (0.54) GAAHSP90AA1HSP90AB1MAPTHTT
SCHEMBL13606210 0.80 HDAC1 (0.43) HDAC1CA12CA1CA9RXFP1
SCHEMBL6176599 0.80 AAK1 (0.47) HDAC1MAPTHTT
SCHEMBL17486759 0.79 HDAC1 (0.48) CYP17A1HDAC1RXFP1NAMPTHTT
SCHEMBL9865843 0.79 KDM5A (0.50) CYP17A1HDAC1CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188292-B1 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D]PYRIMIDIN-4-YL) AMINO]BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER GLAXOSMITHKLINE IP DEV LTD (GB) 2013-05-29 EP disclosed